Perrigo Company plc

PRGO ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $531.6M $558.8M $751.3M $600.7M $1.86B $631.5M $354.3M $551.1M
Accounts Receivable $612.8M $642.3M $739.6M $697.1M $652.9M $593.5M $1.24B $1.07B
Inventory $1.15B $1.08B $1.14B $1.15B $1.02B $1.06B $967.3M $878.0M
Total Current Assets $2.80B $2.48B $2.83B $2.72B $3.86B $3.13B $2.73B $2.90B
Property, Plant & Equipment $898.7M $917.8M $916.4M $926.3M $864.1M $864.6M $774.2M $829.1M
Goodwill $2.05B $3.32B $3.53B $3.49B $3.00B $3.10B $3.10B $3.98B
Intangible Assets (Excl. Goodwill) $4.76B $4.50B $5.00B $5.01B $3.68B $3.89B $4.75B $4.43B
Total Assets $8.54B $9.65B $10.81B $11.02B $10.43B $11.49B $11.30B $10.98B
Liabilities
Accounts Payable $474.5M $495.2M $477.7M $537.3M $411.2M $451.6M $520.2M $474.9M
Total Current Liabilities $1.01B $1.04B $1.59B $1.11B $1.59B $1.38B $1.34B $1.54B
Long-Term Debt $3.60B $3.58B $3.63B $4.07B $2.92B $3.53B $3.37B $3.05B
Total Liabilities $5.60B $5.33B $6.04B $6.18B $5.27B $5.83B $5.50B $5.32B
Stockholders' Equity
Retained Earnings $-3.68B $-2.25B $-2.08B $-2.07B $-1.93B $-1.86B $-1.70B $-1.84B
Total Stockholders' Equity $2.94B $4.32B $4.77B $4.84B $5.15B $5.66B $5.80B $5.67B
← Newer Page 1 of 2 Older →